DrugPatentWatch Database Preview
Profile for Singapore Patent: 184323
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Singapore Patent: 184323
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jun 11, 2031 | Gilead Sciences Inc | HARVONI | ledipasvir; sofosbuvir |
Start Trial | Jun 11, 2031 | Gilead Sciences Inc | SOVALDI | sofosbuvir |
Start Trial | Jun 11, 2031 | Gilead Sciences Inc | EPCLUSA | sofosbuvir; velpatasvir |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |